Monga V - Search Results

1

Developing our knowledge of the quinolone scaffold and its value to anticancer drug design.

Singh Y, Bhatia N, Biharee A, Kulkarni S, Thareja S, Monga V. Singh Y, et al. Among authors: monga v. Expert Opin Drug Discov. 2023 Jul-Dec;18(10):1151-1167. doi: 10.1080/17460441.2023.2246366. Epub 2023 Aug 17. Expert Opin Drug Discov. 2023. PMID: 37592843 Review.

2

Low affinity analogs of thyrotropin-releasing hormone are super-agonists.

Engel S, Neumann S, Kaur N, Monga V, Jain R, Northup J, Gershengorn MC. Engel S, et al. Among authors: monga v. J Biol Chem. 2006 May 12;281(19):13103-13109. doi: 10.1074/jbc.M600440200. Epub 2006 Mar 21. J Biol Chem. 2006. PMID: 16551618 Free article.

3

Synthesis, characterization of (Z)-N-(1-(2-(2-amino-3-(dimethylamino) methyl)phenyl)-5-phenyl-1,3,4, oxadiazol-3(2H)-yl)ethanone analogs as potent antimicrobial and hydrogen peroxide scavenging agents.

Malhotra M, Monga V, Sharma R, Sahu K, Sharma G, Jain J, Deep A. Malhotra M, et al. Among authors: monga v. Med Chem. 2013 Aug;9(5):710-7. doi: 10.2174/1573406411309050011. Med Chem. 2013. PMID: 22974287

4

Corrigendum: The medicinal perspective of 2,4-thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review.

Kajal K, Singh G, Pradhan T, Bhurta D, Monga V. Kajal K, et al. Among authors: monga v. Arch Pharm (Weinheim). 2022 Sep;355(9):e2270016. doi: 10.1002/ardp.202270016. Epub 2022 Jul 15. Arch Pharm (Weinheim). 2022. PMID: 35839460 No abstract available.

5

Molecular docking, 3D-QSAR and simulation studies for identifying pharmacophoric features of indole derivatives as 17β-hydroxysteroid dehydrogenase type 5 (17β-HSD5) inhibitors.

Kulkarni S, Singh Y, Biharee A, Bhatia N, Monga V, Thareja S. Kulkarni S, et al. Among authors: monga v. J Biomol Struct Dyn. 2023;41(22):12668-12685. doi: 10.1080/07391102.2023.2175265. Epub 2023 Feb 6. J Biomol Struct Dyn. 2023. PMID: 36744535

6

Current development of 1,2,3-triazole derived potential antimalarial scaffolds: Structure- activity relationship (SAR) and bioactive compounds.

Abdul Rahman SM, Bhatti JS, Thareja S, Monga V. Abdul Rahman SM, et al. Among authors: monga v. Eur J Med Chem. 2023 Nov 5;259:115699. doi: 10.1016/j.ejmech.2023.115699. Epub 2023 Jul 30. Eur J Med Chem. 2023. PMID: 37542987 Review.

7

Boron in cancer therapeutics: An overview.

Kulkarni S, Bhandary D, Singh Y, Monga V, Thareja S. Kulkarni S, et al. Among authors: monga v. Pharmacol Ther. 2023 Nov;251:108548. doi: 10.1016/j.pharmthera.2023.108548. Epub 2023 Oct 17. Pharmacol Ther. 2023. PMID: 37858628 Review.

8

Rhodanine derivatives: An insight into the synthetic and medicinal perspectives as antimicrobial and antiviral agents.

Chaurasyia A, Chawla P, Monga V, Singh G. Chaurasyia A, et al. Among authors: monga v. Chem Biol Drug Des. 2023 Mar;101(3):500-549. doi: 10.1111/cbdd.14163. Epub 2022 Nov 29. Chem Biol Drug Des. 2023. PMID: 36447391 Review.

9

p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents.

Nayak SK, Khatik GL, Narang R, Monga V, Chopra HK. Nayak SK, et al. Among authors: monga v. Curr Cancer Drug Targets. 2018;18(8):749-772. doi: 10.2174/1568009617666170623111953. Curr Cancer Drug Targets. 2018. PMID: 28669344 Review.

10

Medicinal Perspective of Indole Derivatives: Recent Developments and Structure-Activity Relationship Studies.

Kumar D, Sharma S, Kalra S, Singh G, Monga V, Kumar B. Kumar D, et al. Among authors: monga v. Curr Drug Targets. 2020;21(9):864-891. doi: 10.2174/1389450121666200310115327. Curr Drug Targets. 2020. PMID: 32156235 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters